BRIEFING FOR OWNERS: The MOU, reporting shipments, and you
APC is offering a free one-hour, members-only webinar briefing for owners: "NABP’s Data Collection Tool for MOU Compliance: What Will It Mean for You?"
APC is offering a free one-hour, members-only webinar briefing for owners: "NABP’s Data Collection Tool for MOU Compliance: What Will It Mean for You?"
APC, with our partners has sent a letter to every state boards of pharmacy.
... for writing about the threat to compounded hormones in Townsend Letter: "If We Lose Compounded Bioidentical Hormone Replacement Therapy"
A bill introduced in Congress would be a small but important step toward that frustratingly elusive goal of full provider status for pharmacists.
He is the recipient of the California Pharmacists Association 2021 Steven C. Feldman Compounding Award — "an individual who is a leader in California pharmacy by virtue of his activities to advance the practice of compounding."
A 2020 FDA-funded report published by the National Academies of Science, Engineering, and Medicine on the safety and utility of compounded hormones is compromised by potential bias, conflicts of interest and bad science — so says an independent, third-party analysis.
APC has launched Compounding.com, a new website dedicated to sharing the value of compounded hormone therapy.
APC is offering a free one-hour, members-only webinar briefing for owners: "NABP’s Data Collection Tool for MOU Compliance: What Will It Mean for You?"
APC CEO Scott Brunner was the featured guest on the April 14 edition of Medisca's PhLAG 2021 pod/video cast.
APC and several other organizations have submitted a joint letter to FDA asking that it delay enforcement of the final MOU until at least October 26, 2023.